Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Luci vs Strut Health

By GLP-1 ScorecardUpdated

Luci
Site position #107

Lower grade

Strut Health
Site position #28

Higher grade

Score comparison

Strut Health has the higher recorded score — 79.4/100 to 71/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueStrut Health +6
84
90
Dose & formulationStrut Health +20
75
95
Clinical oversightLuci +16
71
55
Labs & monitoringStrut Health +7
53
60
FulfillmentStrut Health +18
70
88
Contract termsStrut Health +37
55
92
Luci · top barStrut Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricLuciStrut Health
WeighScore71/10079.4/100
GradeCC+
Site position#107#28
Semaglutide$99/mo (starting dose, promotional rate, compounded)Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal
Tirzepatide$145/mo (starting dose, promotional rate, compounded)Oral $199/30 days; injection $219/mo—confirm prescribed dose, quantity and renewal
CoverageCoverage not publishedFAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Luci

Site position #107 · C

Strengths

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

What to consider

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials
Strut Health

Site position #28 · C+

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Strengths

  • Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
  • Provider consultations, follow-ups and shipping are advertised as included
  • Current help describes an account cancellation button; terms also provide an email route
  • Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription

What to consider

  • Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
  • Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
  • 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
  • Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024

Featured provider

Strut Health

Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard